US Stock MarketDetailed Quotes
IART Integra Lifesciences
- 28.680
- -2.950-9.33%
Close Apr 19 16:00 ET
- 28.720
- +0.040+0.14%
Post 16:30 ET
2.25BMarket Cap34.14P/E (TTM)
31.720High27.850Low2.92MVolume31.720Open31.630Pre Close84.16MTurnover4.32%Turnover Ratio34.14P/E (Static)78.60MShares59.10052wk High1.42P/B1.94BFloat Cap27.85052wk Low--Dividend TTM67.55MShs Float77.400Historical High--Div YieldTTM12.24%Amplitude1.500Historical Low28.858Avg Price1Lot Size
Integra Lifesciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -47.08%139.96M | -31.15%58.75M | -60.81%26.77M | -57.46%28.28M | -41.02%26.16M | -15.35%264.47M | 23.18%85.33M | -17.48%68.31M | -27.18%66.48M | -35.81%44.34M |
| Net income from continuing operations | -62.48%67.74M | -62.54%19.83M | -60.94%19.5M | -90.66%4.18M | -26.37%24.23M | 6.79%180.55M | 16.66%52.95M | 15.47%49.92M | 27.72%44.79M | -27.52%32.9M |
| Operating gains losses | 110.42%777K | 110.11%781K | 121.65%100K | -505.00%-81K | -103.23%-23K | 81.15%-7.46M | -2,133.42%-7.73M | -121.26%-462K | -97.39%20K | 101.66%712K |
| Depreciation and amortization | 4.41%123.51M | 5.05%30.99M | 3.70%30.56M | 4.10%30.83M | 4.77%31.14M | -1.28%118.3M | -4.07%29.5M | -2.17%29.47M | -0.48%29.61M | 1.75%29.72M |
| Deferred tax | -159.21%-11.89M | -146.48%-14.85M | 120.27%1.24M | -105.68%-227K | -44.89%1.95M | -66.42%-4.59M | -156.07%-6.02M | 28.96%-6.1M | 208.85%4M | 387.20%3.54M |
| Other non cash items | 299.58%21.24M | 831.71%6.11M | 138.73%3.98M | 268.56%3.3M | 733.23%7.85M | -222.31%-10.64M | -21.81%656K | -578.15%-10.29M | -189.40%-1.96M | -73.27%942K |
| Change In working capital | -106.94%-81.57M | -1.59%10.09M | -969.18%-34.06M | 10.34%-14.99M | -43.14%-42.61M | -317.03%-39.42M | 140.62%10.26M | -153.55%-3.19M | -245.56%-16.72M | -214.62%-29.77M |
| -Change in receivables | 113.55%4.59M | 95.45%-457K | 101.57%224K | 19.97%-5.22M | 422.24%10.04M | -566.69%-33.91M | 1.35%-10.04M | -314.59%-14.24M | -9.44%-6.52M | -118.60%-3.12M |
| -Change in inventory | -105.24%-59.77M | -250.84%-16.42M | -130.01%-15.8M | 64.56%-2.13M | -119.90%-25.42M | -641.94%-29.12M | -152.17%-4.68M | -5.79%-6.87M | -215.12%-6.02M | -395.75%-11.56M |
| -Change in prepaid assets | -69.21%2.65M | 248.73%24.35M | -294.61%-11.19M | -1,001.51%-8.35M | 57.11%-2.16M | 140.73%8.61M | 173.92%6.98M | 258.16%5.75M | 120.64%926K | -41.19%-5.05M |
| -Change in payables and accrued expense | -216.64%-20.23M | -89.46%1.91M | -145.39%-6.24M | -127.30%-10.92M | 48.90%-4.98M | -47.24%17.34M | 1,944.11%18.15M | 108.98%13.75M | -137.43%-4.8M | -167.51%-9.75M |
| -Change in other current assets | -291.15%-8.54M | 102.03%239K | -120.80%-590K | -148.82%-2.18M | -363.21%-6.01M | -127.71%-2.18M | -695.29%-11.76M | 54.77%2.84M | 170.14%4.46M | -78.09%2.28M |
| -Change in other current liabilities | 90.76%-410K | -95.10%483K | 101.78%110K | 335.84%13.07M | -446.31%-14.07M | 68.55%-4.44M | 163.06%9.85M | -700.78%-6.17M | -154.63%-5.54M | 73.34%-2.58M |
| -Change in other working capital | -97.01%128K | -100.74%-13K | -133.31%-583K | ---- | ---- | 15,164.29%4.27M | --1.75M | --1.75M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -47.08%139.96M | -31.15%58.75M | -60.81%26.77M | -57.46%28.28M | -41.02%26.16M | -15.35%264.47M | 23.18%85.33M | -17.48%68.31M | -27.18%66.48M | -35.81%44.34M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -60.77%-94.18M | -4.39%-57.23M | -151.99%-7.7M | -245.66%-15.55M | 2.58%-13.7M | 63.71%-58.58M | -99.45%-54.82M | 274.69%14.81M | 43.19%-4.5M | 88.03%-14.07M |
| Net PPE purchase and sale | -114.32%-66.87M | -641.01%-24.54M | -42.85%-13.08M | -65.28%-15.55M | -46.96%-13.7M | 35.03%-31.2M | 87.93%-3.31M | -25.70%-9.16M | -41.80%-9.41M | -39.70%-9.33M |
| Net intangibles purchase and sale | --0 | --0 | --0 | --0 | --0 | -8,075.86%-4.74M | --0 | --0 | --0 | ---4.74M |
| Net business purchase and sale | --0 | --0 | ---- | ---- | ---- | 75.72%-27.55M | ---51.51M | ---- | ---- | ---- |
| Net investment purchase and sale | -656.39%-27.31M | ---32.69M | --5.38M | ---- | ---- | 6,359.21%4.91M | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -60.77%-94.18M | -4.39%-57.23M | -151.99%-7.7M | -245.66%-15.55M | 2.58%-13.7M | 63.71%-58.58M | -99.45%-54.82M | 274.69%14.81M | 43.19%-4.5M | 88.03%-14.07M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 8.74%-229.93M | 92.95%-6.89M | -549.82%-49.66M | 18.67%-10.69M | -21.89%-162.68M | -156.50%-251.95M | -18,852.21%-97.7M | -538.44%-7.64M | 86.51%-13.15M | -4,326.70%-133.47M |
| Net issuance payments of debt | 150.56%54.5M | 93.58%-6.5M | 1,252.31%74.9M | -2,440.00%-11.7M | -340.00%-2.2M | -7.80%-107.8M | -12,762.50%-101.3M | -712.50%-6.5M | 100.51%500K | 68.75%-500K |
| Net common stock issuance | -120.00%-275M | --0 | ---125M | --0 | -20.00%-150M | ---125M | --0 | --0 | --0 | ---125M |
| Proceeds from stock option exercised by employees | -21.01%4.32M | -94.19%225K | --655K | 214.73%1.11M | 87.73%2.33M | -19.92%5.47M | 1,541.10%3.87M | --0 | -74.44%353K | -44.24%1.24M |
| Net other financing activities | 44.18%-13.74M | -126.10%-615K | 81.26%-214K | 99.26%-104K | -39.17%-12.81M | -387.49%-24.62M | 47.18%-272K | -158.37%-1.14M | -2,970.18%-14M | -153.07%-9.2M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 8.74%-229.93M | 92.95%-6.89M | -549.82%-49.66M | 18.67%-10.69M | -21.89%-162.68M | -156.50%-251.95M | -18,852.21%-97.7M | -538.44%-7.64M | 86.51%-13.15M | -4,326.70%-133.47M |
| Net cash flow | ||||||||||
| Beginning cash position | -11.06%456.66M | -46.53%273.73M | -30.85%309.19M | -24.50%307.37M | -11.06%456.66M | 9.21%513.45M | 8.87%511.94M | 12.52%447.15M | -0.46%407.09M | 9.21%513.45M |
| Current changes in cash | -299.77%-184.15M | 92.01%-5.37M | -140.52%-30.59M | -95.83%2.04M | -45.59%-150.23M | -187.31%-46.06M | -258.78%-67.19M | -0.75%75.48M | 446.28%48.83M | -100.37%-103.19M |
| Effect of exchange rate changes | 136.27%3.89M | -32.50%8.04M | 54.41%-4.87M | 97.57%-213K | 129.58%937K | -13.16%-10.72M | 1,217.37%11.91M | -230.99%-10.69M | -445.39%-8.77M | 67.31%-3.17M |
| End cash Position | -39.47%276.4M | -39.47%276.4M | -46.53%273.73M | -30.85%309.19M | -24.50%307.37M | -11.06%456.66M | -11.06%456.66M | 8.87%511.94M | 12.52%447.15M | -0.46%407.09M |
| Free cash flow | -66.38%73.09M | -51.73%34.22M | -76.86%13.69M | -77.69%12.73M | -58.87%12.45M | -17.77%217.38M | 69.60%70.88M | -21.64%59.16M | -32.58%57.07M | -51.48%30.28M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
